Phase 3 Mental Disorders trials

Showing 76 to 90 of 90. Each trial links to its page on Pharma Observatory.

• Efficacy and Safety of Risperidone Compared With Placebo in the Treatment of Psychotic Symptoms in Patients With Alzheimer's Disease NCT00034762·Phase 3·Completed·Johnson & Johnson Pharmaceutical Research & Development, L.L.C.·Started 2000
• Phase III Randomized, Double-Blind, Placebo-Controlled Study of 3,4-Diaminopyridine for Demyelinating Polyneuropathy NCT00004939·Phase 3·Completed·National Center for Research Resources (NCRR)·Started 1996
• Phase III Multicenter Double Blind Controlled Trial of Human Immune Globulin Therapy in Previously Untreated Patients With Chronic Inflammatory Demyelinating Neuropathy NCT00004286·Phase 3·Completed·National Center for Research Resources (NCRR)·Started 1996
• Phase III Randomized Study of Diazepam Vs Lorazepam Vs Placebo for Prehospital Treatment of Status Epilepticus NCT00004297·Phase 3·Completed·National Institute of Neurological Disorders and Stroke (NINDS)·Started 1995
• Phase III Randomized, Double-Blind Study of Prednisone for Duchenne Muscular Dystrophy NCT00004646·Phase 3·Completed·National Center for Research Resources (NCRR)·Started 1995
• Phase III Randomized, Double-Blind, Sham-Controlled Study of Plasma Exchange for Acute Severe Attacks of Inflammatory Demyelinating Disease Refractory to Intravenous Methylprednisolone NCT00004645·Phase 3·Unknown status·National Institute of Neurological Disorders and Stroke (NINDS)·Started 1995
• Phase III Randomized, Double-Blind, Placebo-Controlled Study of Guanfacine for Tourette Syndrome and Attention Deficit Hyperactivity Disorder NCT00004376·Phase 3·Completed·National Center for Research Resources (NCRR)·Started 1994
• Phase III Randomized, Double-Blind, Placebo-Controlled Study of Oral Topiramate for Lennox-Gastaut Syndrome NCT00004776·Phase 3·Completed·National Center for Research Resources (NCRR)·Started 1993
• Phase III Randomized, Double-Blind, Placebo-Controlled Study of Mexiletine for Painful Diabetic Neuropathy NCT00004647·Phase 3·Completed·National Center for Research Resources (NCRR)·Started 1993
• Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Multiple Sclerosis NCT00004744·Phase 3·Completed·National Institute of Neurological Disorders and Stroke (NINDS)·Started 1993
• Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Chronic Inflammatory Demyelinating Polyneuropathy NCT00004772·Phase 3·Completed·National Center for Research Resources (NCRR)·Started 1992
• Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dichlorphenamide for Periodic Paralyses and Associated Sodium Channel Disorders NCT00004802·Phase 3·Completed·National Center for Research Resources (NCRR)·Started 1992
• Methylprednisolone Given by 24-Hour or 48-Hour Infusion Versus Tirilazad for Acute Spinal Cord Injury NCT00004759·Phase 3·Completed·National Institute of Neurological Disorders and Stroke (NINDS)·Started 1991
• Phase III Randomized, Double-Blind, Placebo-Controlled Study of Copolymer 1 for Relapsing-Remitting Multiple Sclerosis NCT00004814·Phase 3·Completed·National Center for Research Resources (NCRR)·Started 1991
• Phase III Double Blind Trial of Valproate Sodium for Prophylaxis of Post Traumatic Seizures NCT00004817·Phase 3·Completed·National Institute of Neurological Disorders and Stroke (NINDS)·Started 1991